Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

7,150 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    FDA Designates Intellia's Nexiguran Ziclumeran (Nex-z) As A Regenerative Medicine Advanced Therapy

    On November 25, 2024, Intellia Therapeutics announced that its CRISPR-based therapy, nexiguran ziclumeran...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    FDA Establishes Public Docket To Explore Possibility Of Reserving Proprietary Names For Drugs

    This notice initiates a public process to discuss issues around reserving proprietary names. Comments are due October 27, 2014.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
Jones Day
  • Article

    FDA Estimates For Formal Meetings Show Continued Growth Of Biosimilars In The United States

    Among the key aspects in the development of a biosimilar product for the U.S. market is taking advantage of formal meetings with the FDA to gain insight on moving a clinical development program for a proposed biosimilar product forward.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Duane Morris LLP
    Duane Morris LLP
  • Article

    FDA Extends Comment Period For Proposed Rule On Medical Device Classification Procedures

    FDA extended the comment period to September 22 for the proposed medical device classification rule appearing in the March 25 Federal Register.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Extends Comment Period On Two-Phased Chemistry Draft Guidance

    In the December 9, 2014, Federal Register, FDA announced an extension of the comment period on Two-Phased Chemistry, Manufacturing, and Controls Technical Sections.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Clinical Data Standards

    The FDA released a document titled, Validation Rules for Study Data Tabulation Model (SDTM) Formatted Studies.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Final Rule Amending Regulations Relating To Embryos Donated For Reproductive Use

    In the June 22, 2016, Federal Register, FDA issued a final rule amending certain donor eligibility regulations to increase access to embryos donated for reproductive use.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Final Rule On OTC Consumer Antiseptic Washes

    In the September 6, 2016, Federal Register, FDA issued a final rule establishing that certain active ingredients used in OTC consumer antiseptic products intended for use with water are not generally recognized as safe and effective and are misbranded.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Issues Final Rule On Regulation Of Laboratory Developed Tests

    On April 29, 2024, the U.S Food and Drug Administration (FDA) announced its final rule on Laboratory Developed Tests (LDTs).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    FDA Issues Final Rule To More Closely Align With ISO 13485

    On 2 February 2024, the US Food and Drug Administration (FDA) published its much anticipated final rule amending the medical device Quality System Regulation...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Arnold & Porter
    Arnold & Porter
  • Article

    FDA Issues Guidance On Chemistry, Manufacturing, And Controls (CMC) Postapproval Manufacturing Changes

    The guidance was issued to cover matters of minimal risk because the FDA was getting swamped with supplemental applications to the new drug applications.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    FDA Issues Guidance On Cosmetic Registration And Listing

    Cosmetic companies are required to submit facility registration and product listing information on cosmetic products that they manufacture, or other procedures, including manipulation, sampling...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Foley & Lardner LLP
    Foley & Lardner LLP
  • Article

    FDA Issues New Draft Guidance Regarding Informed Consent

    The FDA announced the issuance of the draft Guidance for IRBs, Clinical investigators and Sponsors about Informed Consent Information Sheet.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    FDA Launches Food Safety Challenge To Target Salmonella Detection

    FDA recently announced its first Food Safety Challenge to encourage breakthrough ideas for detecting Salmonella.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Outlines Plan To Regulate Next Generation Gene Sequencing Tests

    At a recent public workshop, FDA's Office of In Vitro Diagnostics and Radiological Health addressed the need for FDA to develop a regulatory system for next generation sequencing tests.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Proposes Framework For Regulating Software As A Medical Device

    The Food and Drug Administration (FDA) recently released new draft guidance documents to clarify its approach to regulating software as a medical device.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    FDA Proposes Phased Approach To Regulating Laboratory Developed Tests

    On September 29, 2023, the U.S. Food and Drug Administration (FDA) posted and scheduled for publication its long-awaited proposed rule concerning FDA regulation of laboratory developed tests (LDTs).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    FDA Proposes Reclassification Of Antigen-Based Rapid Influenza Virus Detection Systems From Class I To Class II

    FDA proposed a reclassification of antigen-based rapid influenza virus detection test systems intended to detect influenza virus direction.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Releases Modifications To FDA-Recognized Consensus Standards

    In the July 9, 2014, Federal Register, FDA announced modifications to the list of recognized standards the Agency uses in premarket reviews.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    FDA Reopens Nominations For Two Lists Of Bulk Drug Substances Used To Compound Drug Products

    FDA has provided more details in the current call for nominations to assist stakeholders with making appropriate nominations.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Showing 441–460 of 7150 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics